+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

I

Actively Recruiting

Researchers are evaluating whether an interactive and informative exhibition in the waiting room of a primary care clinic can help reduce the use of benzodiazepines among adult patients. The study compares benzodiazepine consumption before and after this exhibition is implemented. The primary goal is to see if this educational approach can lower the number of people using these medications long term. Participants will be exposed to an interactive exhibition focusing on the risks of chronic benzodiazepine use. Additionally, health professionals at the center will attend a single informative session on the same topic. The study includes two groups patients who visited the clinic before the exhibition was introduced and those who attend afterward. During the study, participants benzodiazepine use will be tracked over one year to assess changes in chronic treatment patterns. Researchers will collect data on medication use to measure the impact of the intervention. The trial is observational, and participants will not receive any medication from the study team. The study runs from June 2024 to July 2027.

Age: 18Years - 99YearsAll Genders
1 location
E

Actively Recruiting

Researchers are investigating whether loneliness increases the risk of developing dementia in older adults who have already been diagnosed with mild cognitive impairment MCI. The study focuses on understanding this relationship over a 12-month follow-up period to provide insight into factors that may influence the progression from MCI to dementia. Participants are adults aged 70 years or older receiving care at a specialized dementia unit. The study separates participants into two groups based on whether they experience loneliness or not. No experimental treatments are given, as this is an observational study. Researchers will monitor participants over one year, observing their cognitive status and collecting relevant data to track changes in their condition. Participants will undergo regular assessments to evaluate their cognitive abilities and check for signs of dementia. The primary outcome is the diagnosis of dementia after 12 months of follow-up. Informed consent is required, and participants or their legal representatives must be able to collaborate with study procedures. The study is led by the Consorci Sanitari de lAlt Peneds i Garraf and plans to complete by September 2028.

Age: 70Years +All Genders
1 location
R

Actively Recruiting

Researchers are evaluating the safety of remote consultations, including video and telephone appointments, compared to traditional face-to-face consultations for patients in a hospital setting. This randomized controlled trial aims to assess whether remote follow-up is as safe as in-person visits by measuring complications related to the patients underlying diseases over a 12-month period. The study includes a total of 2136 patients randomly assigned to one of three groups face-to-face consultation, video consultation, or telephone consultation. Participants will receive follow-up care through either in-person visits or remote consultations delivered by phone or video. Physicians will schedule at least three visits per participant a baseline screening visit, several intermediate visits based on medical need, and a final visit around 12 months after enrollment or earlier if the patient is discharged or discontinues early. Remote consultation patients will be reminded of appointments via text or call. Telephone consultations involve the doctor calling the patient or their family at the scheduled time, while video consultations use a secure application with a virtual waiting room. During the study, participants will be monitored for complications, serious adverse events, avoidable hospitalizations, and unscheduled medical contacts. Researchers will also evaluate healthcare costs, usability of the video system, and satisfaction of both patients and health professionals with the care process. All interactions, including phone calls for control participants, will be recorded. The total participation duration is about 12 months, with physicians able to schedule or cancel appointments as needed throughout this period.

All AgesAll GendersPhase Not Applicable
3 locations